Dr. Copeland on the Prevalence of Ovarian Cancer in the United States

Video

In Partnership With:

Larry J. Copeland, MD, discusses the prevalence of ovarian cancer in the United States.

Larry J. Copeland, MD, professor, Obstetrics & Gynecology, College of Medicine, The Ohio State University Comprehensive Cancer Center—James, discusses the prevalence of ovarian cancer in the United States.

The prevalence trends of ovarian cancer are up, says Copeland. The prevalence trends are up, not because of the frequency of occurrence, but because patients are living longer. Additional research has the potential to exaggerate the prevalence of ovarian cancer even further.

The etiology of ovarian cancer has made it challenging to develop preventative and early detection strategies, says Copeland. Currently, tube removal is implemented as a preventative strategy.

Going forward, additional investigation is needed to understand how blood work, urine analysis, and imaging can aid in early detection of ovarian cancer, concludes Copeland.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine